Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Cohen

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Rheumatology (Oxford, England)|January 25, 2011
Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnessesCecile Marchand-Janssen, Pierre Loulergue, Luc Mouthon, et al.
Rheumatology (Oxford, England)|December 13, 2016
Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French populationBenjamin Terrier, Agnès Dechartres, Christophe Deligny, et al.
Arthritis and Rheumatism|February 13, 2003
Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patientsLoïc Guillevin, Pascal Cohen, Alfred Mahr, et al.
Annals of Internal Medicine|November 3, 2005
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndromeRégis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, et al.
Rheumatology (Oxford, England)|September 5, 2014
Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomesGonzalo De Luna, Benjamin Terrier, Pierre Kaminsky, et al.
Clinical and Experimental Rheumatology|April 20, 2017
Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trialMaxime Samson, Xavier Puéchal, Luc Mouthon, et al.
Rheumatology (Oxford, England)|October 7, 2020
Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitisJonathan London, Nicolas Dumoitier, Sébastien Lofek, et al.
Rheumatology (Oxford, England)|October 26, 2021
Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitisBoris Sorin, Maxime Samson, Cécile-Audrey Durel, et al.
Seminars in Arthritis and Rheumatism|October 15, 2013
Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: a retrospective multicenter studyJean-Christophe Lega, Raphaèle Seror, Thomas Fassier, et al.
The Journal of Rheumatology|November 18, 2011
Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitisClaire Roubaud-Baudron, Christian Pagnoux, Nadine Méaux-Ruault, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Rheumatology (Oxford, England)|January 25, 2011
Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnessesCecile Marchand-Janssen, Pierre Loulergue, Luc Mouthon, et al.
Rheumatology (Oxford, England)|December 13, 2016
Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French populationBenjamin Terrier, Agnès Dechartres, Christophe Deligny, et al.
Arthritis and Rheumatism|February 13, 2003
Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patientsLoïc Guillevin, Pascal Cohen, Alfred Mahr, et al.
Annals of Internal Medicine|November 3, 2005
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndromeRégis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, et al.
Rheumatology (Oxford, England)|September 5, 2014
Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomesGonzalo De Luna, Benjamin Terrier, Pierre Kaminsky, et al.
Clinical and Experimental Rheumatology|April 20, 2017
Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trialMaxime Samson, Xavier Puéchal, Luc Mouthon, et al.
Rheumatology (Oxford, England)|October 7, 2020
Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitisJonathan London, Nicolas Dumoitier, Sébastien Lofek, et al.
Rheumatology (Oxford, England)|October 26, 2021
Rituximab plus methotrexate combination as a salvage therapy in persistently active granulomatosis with polyangiitisBoris Sorin, Maxime Samson, Cécile-Audrey Durel, et al.
Seminars in Arthritis and Rheumatism|October 15, 2013
Characteristics, prognosis, and outcomes of cutaneous ischemia and gangrene in systemic necrotizing vasculitides: a retrospective multicenter studyJean-Christophe Lega, Raphaèle Seror, Thomas Fassier, et al.
The Journal of Rheumatology|November 18, 2011
Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitisClaire Roubaud-Baudron, Christian Pagnoux, Nadine Méaux-Ruault, et al.
Pageof 12